Consistently, overexpression of AMPK has been linked to a shorter metastasis‐free survival of breast cancer patients.[47] The authors confirmed their findings by knock‐down of PRKAA1 in 4T1 breast cancer cells which reduced the lung metastasis capabilities of the cells in vivo. Here, PRKAB1 is linked to breast carcinoma.